Pegipeg 80mcg Injection: Effective Solution for Your Needs

Pegihep 80mcg Injection

Description:

• Pegihep 80mcg Injection is an antineoplastic drug belonging to the category of interferons.
• It contains the active ingredient Pegylated Interferon Alpha-2B.
• It is used to treat chronic hepatitis C infection in patients above 18 years of age with compensated liver disease.

Usage:

• Chronic Hepatitis C (CHC) is the primary condition treated with Pegihep 80mcg Injection.

Mechanism of Action:

• Pegihep 80mcg Injection works by stimulating the body's immune system to fight off viral infections and cancer cells.
• It activates certain immune cells, such as natural killer cells and T-cells, to attack and eliminate the infected virus or cancerous cells.

Dosage and Administration:

• The recommended dose is 1.5 micrograms/kg/week.
• Administered as a subcutaneous injection (under the skin).
• The dosage and administration frequency are determined by the doctor based on the patient's condition.

Precautions:

• Use with caution in patients with creatinine clearance below 50 mL/min.
• Contraindicated in patients with decompensated liver disease.
• Not recommended for pregnant women as it may cause fetal harm.
• Avoid breastfeeding during treatment.
• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.

Side Effects:

• Serious: Low or high BP, increased heart rate, depression.
• Common: Tiredness, flu-like symptoms, headache, loss of appetite, hair loss, muscle pain, anxiety, anaemia, irritability, insomnia, fainting, eye irritation and disturbance, injection site reactions, weight loss.

Safety Advice:

• Pregnancy: Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
• Breastfeeding: It is unsafe to breastfeed during the treatment.
• Lungs: Consult your doctor if you have any lung diseases before starting the treatment.
• Liver: Inform your doctor if you have any liver problems before taking Pegihep 80mcg Injection.
• Alcohol: Consuming alcohol may affect the effectiveness of the Pegihep 80mcg Injection.
• Driving: It is unsafe to drive vehicles or operate heavy machinery after taking Pegihep 80mcg Injection, as it may cause dizziness and impair your concentration.

Storage:

• Store Pegihep 80mcg Injection in a controlled room temperature at (25°C).
• Do not freeze.
• Keep it out of reach from children.

FAQs:

1. Why is PEG added to interferon?

   • By adding PEG, interferon alpha-2b has a longer half-life, meaning that it remains in the body for a longer period of time before being cleared. Also, it can reduce the immune response to the drug, by decreasing the likelihood of adverse reactions.

2. Can Pegihep 80mcg Injection be used in combination with other drugs?

   • Yes, it is used in combination with the antiviral drug ribavirin. This combination therapy has been shown to be more effective in achieving sustained virologic response (SVR) than using Pegihep 80mcg Injection alone.

3. Does Pegihep 80mcg Injection cause hair loss?

   • Thinning or loss of your hair will usually start within two to four weeks of your first dose of Pegihep 80mcg Injection. Consult your doctor if you have excessive hair loss.

4. What are the contraindications to Pegihep 80mcg Injection?

   • This Pegihep 80mcg Injection is contraindicated in patients with decompensated liver disease.

5. Which condition is treated by Pegihep 80mcg Injection?

   • Pegihep 80mcg Injection is often used in combination with other antiviral medications to treat chronic hepatitis B and C infections.

6. Does Pegihep 80mcg Injection weaken the immune system?

   • No, Pegihep 80mcg Injection does not weaken the immune system, but rather helps it to work more efficiently against the virus.

Fact Box:

• Molecule name: Pegylated Interferon Alpha-2B
• Therapeutic class: Antineoplastics
• Pharmacological class: Interferons
• Indications: Chronic Hepatitis C (CHC)

Tags: pegihep, injection, medicine, 80mcg, pharmaceutical, healthcare